Pregnancy, High Risk Clinical Trial
Official title:
Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)
Pregnancy is associated with a increased risk of developing blood clots. There is nearly a 5 times greater risk of developing a blood clot in pregnancy. Lovenox is a medication that helps to prevent the body from developing clots. It is safe to use in pregnancy. Previous studies have demonstrated that despite recommendation of Lovenox, to prevent blood clots, the majority of patient's (70 to 90%) did not receive adequate levels of Lovenox at times throughout the day, which likely increases the risk of developing clots. The increase in blood volume and increase in kidney function that occurs in pregnancy may contribute to the inadequate levels. Currently the recommendation for pregnant and nonpregnant patients requiring Lovenox, is to calculate the daily dose of Lovenox and split the dose, giving half in the morning and the other half in the evening. This research study proposes that due to changes in the body during pregnancy that the daily Lovenox dosing be split into three times a day to achieve more consistent levels of Lovenox than twice a day in pregnant women.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03651843 -
Perception of Risks Into Work During Pregnancy Among Post-partum Women in the Lille Metropolis
|
||
| Active, not recruiting |
NCT05656352 -
Validation of a Non-invasive Hemoglobin Measurement Device in Pregnancy and Postpartum in Kenya, Pakistan, and Zambia
|
||
| Not yet recruiting |
NCT06430853 -
Psychobiological Interventions in Pregnancy
|
N/A | |
| Completed |
NCT05316415 -
The Effects of Music on the Anxiety and Sleep Quality of Pregnant Women on Bed Rest for a High-risk Pregnancy
|
N/A | |
| Not yet recruiting |
NCT03985618 -
The MODE Trial: Planned Caesarean Section Versus Induction of Labour for Women With Class III Obesity
|
N/A | |
| Completed |
NCT02008097 -
Clinical Benefits of B-Flow Ultrasound
|
N/A | |
| Recruiting |
NCT05922033 -
Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)
|
Phase 4 | |
| Completed |
NCT03413631 -
A Prenatal Mentalization-focused 4D Ultrasound and a Pregnancy Diary Intervention for Substance-abusing Women
|
N/A | |
| Not yet recruiting |
NCT05388643 -
Early Detection of Gestational Diabetes Mellitus in Pregnancy
|
N/A | |
| Not yet recruiting |
NCT05317585 -
Continuous Glucose Monitor Use in Pregnancy
|
N/A | |
| Completed |
NCT03334149 -
Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension
|
N/A | |
| Completed |
NCT03646487 -
A Randomized Placebo Controlled Pilot Study of Probiotic Supplementation in At-risk Pregnant Women
|
N/A | |
| Recruiting |
NCT05198206 -
Pregnant Women With Pulmonary Hypertension in China
|
||
| Recruiting |
NCT05739123 -
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
|
||
| Recruiting |
NCT05807256 -
Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases
|
||
| Completed |
NCT04874285 -
Use of Dietary Supplements in Patients at Risk of Abortion Treated With Progesterone.
|
N/A | |
| Not yet recruiting |
NCT05662462 -
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
|
N/A | |
| Recruiting |
NCT03975894 -
TAPS2 Transfusion Antenatally in Pregnant Women With SCD
|
Phase 2 | |
| Recruiting |
NCT05597943 -
mHealth Smartphone App and Postpartum Glucose Intolerance for Patients With GDM
|
N/A | |
| Recruiting |
NCT04924504 -
Mechanisms Behind Severe Insulin Resistance During Pregnancy in Women With Glucose Metabolic Disorders (SIR-MET)
|